("PolyPid" or the "Company"), unveiled its long-acting GLP-1 receptor agonists (glucagon-like peptide-1 RA) delivery platform which aims to subcutaneously release GLP-1 RA for approximately 60 days, significantly longer than current weekly injection regimens
Epithalon is known for its anti-aging properties, potentially lengthening telomeres and supporting cellular health, while Thymalin plays a role in regulating the immune system and promoting immune response
For instance, people with a history of thyroid cancer or certain thyroid diseases, pancreatitis, or kidney disease may be advised against using it
Since then, several others have followed, including dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and the latest FDA-approved medication, tirzepatide (Mounjaro, Zepbound)